| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.35 | 5e-11 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.2 | 5e-07 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.27 | 2e-06 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.31 | 2e-06 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-06 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.28 | 3e-05 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-05 |
| mRNA | MST-312 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |